Single-Use/Disposable Endoscopy Market See Incredible Growth 2021-2030

The global single-use/disposable endoscopy market is witnessing a significant increase in size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 40.17% during the forecast period, 2021-2030. Presently, more than XX companies are operating in this market, including already existing and emerging medical device companies.

Owing to the COVID-19 pandemic, the secondary procedures including endoscopy services were shut down in 2020. However, the pandemic has created a positive impact on the net revenue in single-use endoscopes primarily due to the increase in infectious diseases and increasing awareness among patients regarding concern about hygiene has leaded to increase in demand of single-use endoscopes.

The global single-use/disposable endoscopy market was estimated at $471.7 Million in 2019 and is expected to reach $22,720.1 Million by 2030

Market Challenges

• Dominance of Reusable Endoscope Enterprises

Market Trends

• Growing Adoption of Single-Use Devices

Market Opportunities

• Development of Multipurpose Single-Use/Disposable Endoscope

• Rising Usage of Single-Use/Disposable Endoscope for Bronchoscopy and Hysteroscopy procedures

Key Companies Profiled

3NT Medical Ltd., Ambu A/S, Boston Scientific Corporation, Coloplast A/S, Corinth MedTech, Inc., Hill-Rom Holdings, Inc., HOYA Corporation, Integra LifeSciences Holdings Corporation, Integrated Endoscopy, KARL STORZ SE& CO.KG, OBP Medical Corporation, OUT Medical INC., PArburch Medical Developments Ltd., and Prosurg Inc.

Key Questions Answered in this Report:

•   What are the key regulations abiding the development, commercialization, and clinical-use of single-use/disposable endoscope, across different regions?
•   What are the key technological developments on which the current industry leaders are spending their major share of research and development (R&D) investment?
•   Who are the leading players which hold significant dominance on the global single-use/disposable endoscope market, currently?
•   What are the key strategies incorporated by the players of the global single-use/disposable endoscope market, to sustain the competition and retain their supremacy?
•   What is the current annual demand for a single-use/disposable endoscope across different regions and its growth potential in the forecast period?
•   What is the current market potential of single-use/disposable endoscope and what are the factors deciding the growth potential of a single-use/disposable endoscope, in the forecast period?
•   What is the current revenue contribution of different applications and how would it evolve in the forecast period?
•   What are the products in the pipeline, expected to be launched during the forecast period?
•   What is the difference between a reusable endoscope and a single-use endoscope?
•   What is the current demand contribution of different end-user types and how would it evolve in the forecast period?
•   Which countries contribute to the major share of current demand and which countries hold significant scope for expansion for business activities, by players of the global single-use/disposable endoscopy market?

Request a Sample- https://bisresearch.com/requestsample?id=1047&type=download

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing microbiome therapeutics market is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development. Impact Several techniques are employed in ...

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...

Market Research Reports

Search This Blog